Search

Your search keyword '"Skibitsky VV"' showing total 2 results
Start Over Author "Skibitsky VV" Topic coronavirus infections
2 results on '"Skibitsky VV"'

1. [Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association].

Author

Shlyakhto YV, Arutyunov GP, Belenkov YN, Tarlovskaya EI, Konradi AO, Panchenko EP, Yavelov IS, Tereshchenko SN, Ardashev AV, Arutyunov AG, Grigorieva NY, Dzhunusbekova GA, Drapkina OM, Koziolova NA, Komarov AL, Kropacheva ES, Malchikova SV, Mitkovskaya NP, Orlova YA, Petrova MM, Rebrov AP, Sisakian H, Skibitsky VV, Sugraliyev AB, Fomin IV, Chesnikova AI, Shaposhnik II, Zhelyakov EG, Kanorskii SG, Kolotsey LV, and Snezhitskiy VA

Subjects
Anti-Arrhythmia Agents therapeutic use, Betacoronavirus, COVID-19, Humans, Russia, SARS-CoV-2, Societies, Medical, COVID-19 Drug Treatment, Anticoagulants therapeutic use, Cardiology, Coronavirus Infections drug therapy, Coronavirus Infections epidemiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Pandemics, Pneumonia, Viral drug therapy, Pneumonia, Viral epidemiology
Abstract

This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed.

Published
2020
Full Text
View/download PDF

2. [The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange].

Author

Arutyunov GP, Koziolova NA, Tarlovskaya EI, Arutyunov AG, Grigorjeva NY, Dzhunusbekova GA, Malchikova SV, Mitkovskaya NP, Orlova YA, Petrova MM, Rebrov AP, Sisakyan AS, Skibitsky VV, Sugraliev AB, Fomin IV, Chesnikova AI, and Shaposhnik II

Subjects
Betacoronavirus, COVID-19, Hemoglobins, Humans, Hypoxia, Iron, Pandemics, Porphyrins, SARS-CoV-2, Blood Gas Analysis, Blood Transfusion, Coronavirus Infections physiopathology, Hemostasis, Pneumonia, Viral physiopathology
Abstract

The article discusses pathogenesis and treatment of COVID-19. The authors presented state-of-the-art insight into hemostatic disorders in patients with COVID-19 and clinical recommendations on prevention of thrombosis and thromboembolism in patients infected with SARS-CoV-2. The article discussed in detail a new hypothesis proposed by Chinese physicians about a new component in the pathogenesis of COVID-19, namely, about the effect of SARS-CoV-2 virus on the hemoglobin beta-chain and the formation of a complex with porphyrin, which results in displacement of the iron ion. Thus, hemoglobin loses the capability for transporting oxygen, which aggravates hypoxia and worsens the prognosis. The article stated rules of hemotransfusion safety in the conditions of COVID-19 pandemic.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results